Kim Beong Ki, Choi Hangseok, Kim Chi Young
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.
Medical Science Research Center, Korea University College of Medicine, Seoul, Republic of Korea.
J Thorac Dis. 2024 Jan 30;16(1):439-449. doi: 10.21037/jtd-23-1369. Epub 2024 Jan 12.
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an innovative tool for diagnosing mediastinal diseases. We investigated the factors affecting the diagnostic yield of EBUS-TBNA and evaluated whether the effects of these factors (number of biopsies, core tissue acquisition rate, and diameter and volume of tissue) vary depending on computed tomography (CT) and/or positron emission tomography (PET)/CT results.
We retrospectively analyzed lung cancer patients who underwent EBUS-TBNA at Korea University Ansan Hospital (January 2019-December 2022). Patients in whom EBUS-TBNA failed and those with missing diameter or volume data and no imaging data interpretation were excluded. Subgroup analysis was performed by dividing the patients into None (no cancer detected on CT or PET/CT), Either (cancer detected on either CT or PET/CT), and Both (cancer detected on both CT and PET/CT) groups.
In all, 228 patients were enrolled; 351 lymph node stations were analyzed. The median age of the patients was 69 years (male, 76.8%). Adenocarcinoma (28.5%) was the most common diagnosis. EBUS-TBNA was predominantly performed at station #4R (30.5%). Each examination involved two stations with a total procedure time of 30 minutes. An increased number of passes led to a higher diagnostic yield for EBUS-TBNA (P<0.001). Additionally, successful tissue sampling was associated with a large diameter (P=0.016) and volume (P=0.002) of the tissue. The effect of these factors was modified by imaging results. In the None and Either groups, an increase in the pass number was correlated with an increased diagnostic yield (adjusted P=0.003 and 0.007, respectively). However, in the Both group, it was not significant and remained at a suggestive level (P=0.304). The diameter and volume did not differ significantly across subgroups (adjusted P>0.05).
Increasing the number of passes during EBUS-TBNA can maximize the diagnostic yield, especially when CT and/or PET/CT results are inconclusive.
支气管内超声引导下经支气管针吸活检术(EBUS-TBNA)是诊断纵隔疾病的一种创新工具。我们研究了影响EBUS-TBNA诊断率的因素,并评估了这些因素(活检次数、核心组织获取率以及组织的直径和体积)的影响是否因计算机断层扫描(CT)和/或正电子发射断层扫描(PET)/CT结果而异。
我们回顾性分析了在韩国大学安山医院接受EBUS-TBNA的肺癌患者(2019年1月至2022年12月)。排除EBUS-TBNA失败的患者以及直径或体积数据缺失且无影像数据解读的患者。通过将患者分为无(CT或PET/CT未检测到癌症)、任一(CT或PET/CT检测到癌症)和两者(CT和PET/CT均检测到癌症)组进行亚组分析。
总共纳入228例患者;分析了351个淋巴结站。患者的中位年龄为69岁(男性,76.8%)。腺癌(28.5%)是最常见的诊断。EBUS-TBNA主要在4R站进行(30.5%)。每次检查涉及两个站,总操作时间为30分钟。穿刺次数增加导致EBUS-TBNA的诊断率更高(P<0.001)。此外,成功获取组织与组织的大直径(P=0.016)和体积(P=0.002)相关。这些因素的影响因影像结果而改变。在无和任一组中,穿刺次数增加与诊断率提高相关(调整后P分别为0.003和0.007)。然而,在两者组中,这并不显著,仍处于提示水平(P=0.304)。各亚组之间的直径和体积无显著差异(调整后P>0.05)。
增加EBUS-TBNA期间的穿刺次数可使诊断率最大化,尤其是当CT和/或PET/CT结果不确定时。